MY184297A - Water soluble pharmaceutical film with enhanced stability - Google Patents

Water soluble pharmaceutical film with enhanced stability

Info

Publication number
MY184297A
MY184297A MYPI2016701359A MYPI2016701359A MY184297A MY 184297 A MY184297 A MY 184297A MY PI2016701359 A MYPI2016701359 A MY PI2016701359A MY PI2016701359 A MYPI2016701359 A MY PI2016701359A MY 184297 A MY184297 A MY 184297A
Authority
MY
Malaysia
Prior art keywords
film
moisture
curving
sticky
melt
Prior art date
Application number
MYPI2016701359A
Other languages
English (en)
Inventor
Anwar Siraj Daud
Nidhi Prakash Sapkal
Minal Nandkumar Bonde
Original Assignee
Zim Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zim Laboratories Ltd filed Critical Zim Laboratories Ltd
Publication of MY184297A publication Critical patent/MY184297A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
MYPI2016701359A 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability MY184297A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3221MU2013 IN2013MU03221A (fr) 2013-10-14 2014-10-13
PCT/IN2014/000652 WO2015083181A2 (fr) 2013-10-14 2014-10-13 Pellicule pharmaceutique soluble dans l'eau présentant une stabilité améliorée

Publications (1)

Publication Number Publication Date
MY184297A true MY184297A (en) 2021-03-31

Family

ID=53274239

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2016701359A MY184297A (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability

Country Status (8)

Country Link
BR (1) BR112016008356B1 (fr)
CA (1) CA2927334C (fr)
CL (1) CL2016000880A1 (fr)
EA (1) EA038558B1 (fr)
IN (1) IN2013MU03221A (fr)
MY (1) MY184297A (fr)
UA (1) UA123893C2 (fr)
WO (1) WO2015083181A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10660862B2 (en) * 2013-12-17 2020-05-26 Zim Laboratories Limited Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
JP2020512309A (ja) * 2017-03-30 2020-04-23 インテルジェンクス コーポレーションＩｎｔｅｌｇｅｎｘ Ｃｏｒｐ． ロイコトリエン受容体拮抗薬のバイオアベイラビリティの改善のための処理方法及び装置
FR3082851B1 (fr) * 2018-06-25 2022-09-02 Biomerieux Sa Procede de detection et/ou d'identification d'au moins un microorganisme cible present sur une surface.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5947987B2 (ja) * 1979-10-08 1984-11-22 富士写真フイルム株式会社 加筆・修正可能なマツトフイルム
US4664859A (en) * 1983-12-02 1987-05-12 Vcf Films Inc. Div. Of Pmc Process for solvent casting a film
US5272191A (en) * 1991-08-21 1993-12-21 Fmc Corporation Cold water soluble films and film forming compositions
US6966960B2 (en) * 2003-05-07 2005-11-22 Hewlett-Packard Development Company, L.P. Fusible water-soluble films for fabricating three-dimensional objects
WO2005084636A2 (fr) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited Procede de preparation d'une composition pharmaceutique a liberation controlee de metoprolol
KR100705210B1 (ko) * 2004-09-23 2007-04-06 주식회사 한독약품 경구투여를 위한 당뇨병 치료용 약제학적 복합제제
US20090162516A1 (en) * 2007-12-21 2009-06-25 Brown Solomon E Edible, water-soluble film

Also Published As

Publication number Publication date
UA123893C2 (uk) 2021-06-23
BR112016008356A2 (pt) 2017-08-01
CA2927334A1 (fr) 2015-06-11
CL2016000880A1 (es) 2017-01-27
IN2013MU03221A (fr) 2015-07-03
EA038558B1 (ru) 2021-09-14
EA201690751A1 (ru) 2016-08-31
WO2015083181A2 (fr) 2015-06-11
WO2015083181A3 (fr) 2015-12-03
CA2927334C (fr) 2023-08-29
BR112016008356B1 (pt) 2022-12-13

Similar Documents

Publication Publication Date Title
CY1120492T1 (el) Μια μορφοποιηση φαρμακου καθυστερημενης εκλυσης
BR112018073703A2 (pt) emplastro para pele ou ferida, composição farmacêutica e método para a liberação de uma substância ativa
SG10201808743VA (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
AR063468A1 (es) Composiciones farmaceuticas
BR112016002205A2 (pt) filmes orodispersíveis
IL299897B2 (en) Devices and methods for administering multiple units of drug
WO2010042798A3 (fr) Films en soie améliorés contenant du glycérol
MX356111B (es) Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata.
MY167777A (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
MY184297A (en) Water soluble pharmaceutical film with enhanced stability
CY1122114T1 (el) Καταπινομενα δισκια ν-ακετυλοκυστεϊνης
WO2015107544A3 (fr) Microémulsion pharmaceutique immobilisée dans une matrice polymère mince et ses procédés de fabrication
WO2013013038A3 (fr) Agents dopants et leurs compositions polymères pour la libération contrôlée de médicaments
PH12015502556A1 (en) Modified release formulation
CY1123202T1 (el) Σκευασμα υδροκορτιζονης ελεγχομενης απελευθερωσης
WO2016140933A3 (fr) Compositions d'ibuprofène solubles à libération immédiate
BR112017002719A2 (pt) copolímero em bloco de lactídeo e método de preparação
EA201390979A1 (ru) Композиции бензимидазолов с модифицированным высвобождением
PH12016500693B1 (en) Slow-release solid oral compositions
BR112015010243A2 (pt) dispersão sólida, composição para administração oral, composição farmacêutica, e, método para preparar uma dispersão sólida
EA201001245A1 (ru) Содержащая эстрадиол система доставки лекарственного средства
JP2013249283A5 (fr)
WO2018108939A3 (fr) Forme posologique orale pharmaceutique solide à libération de principe actif prolongée comprenant du mirabegron
GB2509460A (en) Coating Composition
FI20135755L (fi) Menetelmä vesiliukoisen kalvon valmistamiseksi ja kalvon käytöt